Home › Funds › Point72 Asset Management › FATE
Point72 Asset Management position in FATE
FATE THERAPEUTICS INC · Health Care
Latest position (Q2 2026)442.23K sh
Reported value held$1.19M
Portfolio Weight0.00%
First reportedQ2 2023
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2023 | 10.14K | $48.25K | New |
| Q3 2023 | 73.40K | $155.61K | Add |
| Q4 2023 | 3.49M | $13.05M | Add |
| Q1 2024 | 1.58M | $11.63M | Reduce |
| Q4 2025 | 1.53M | $1.50M | New |
| Q1 2026 | 43.12K | $51.74K | Reduce |
| Q2 2026 | 442.23K | $1.19M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding FATE
- BlackRock Inc 7.30M sh · $19.71M · Q2 2026
- AQR Capital Management 3.84M sh · $10.36M · Q2 2026
- Two Sigma Investments 3.59M sh · $9.69M · Q2 2026
- Vanguard Group 8.97M sh · $8.82M · Q4 2025
- Renaissance Technologies 2.98M sh · $8.05M · Q2 2026
- Millennium Management 2.43M sh · $6.57M · Q2 2026
- Goldman Sachs Group 2.05M sh · $5.53M · Q2 2026
- Geode Capital Management 1.32M sh · $3.57M · Q2 2026
- Citadel Advisors 1.09M sh · $2.95M · Q2 2026
- Morgan Stanley 694.58K sh · $1.88M · Q2 2026
- Charles Schwab Investment Management 610.95K sh · $1.65M · Q2 2026
- UBS Group AG 590.18K sh · $1.59M · Q2 2026